Prasanna Jagannathan
Prasanna Jagannathan
Assistant Professor of Medicine, Stanford University
Verified email at stanford.edu
Title
Cited by
Cited by
Year
Dihydroartemisinin–piperaquine for the prevention of malaria in pregnancy
A Kakuru, P Jagannathan, MK Muhindo, P Natureeba, P Awori, ...
New England Journal of Medicine 374 (10), 928-939, 2016
1592016
IFNγ/IL-10 co-producing cells dominate the CD4 response to malaria in highly exposed children
P Jagannathan, I Eccles-James, K Bowen, F Nankya, A Auma, S Wamala, ...
PLoS Pathog 10 (1), e1003864, 2014
1072014
Increasing incidence of malaria in children despite insecticide-treated bed nets and prompt anti-malarial therapy in Tororo, Uganda
P Jagannathan, MK Muhindo, A Kakuru, E Arinaitwe, B Greenhouse, ...
Malaria journal 11 (1), 1-8, 2012
902012
FCRL5 delineates functionally impaired memory B cells associated with Plasmodium falciparum exposure
RT Sullivan, CC Kim, MF Fontana, ME Feeney, P Jagannathan, MJ Boyle, ...
PLoS Pathog 11 (5), e1004894, 2015
872015
Loss and dysfunction of Vδ2+ γδ T cells are associated with clinical tolerance to malaria
P Jagannathan, CC Kim, B Greenhouse, F Nankya, K Bowen, ...
Science translational medicine 6 (251), 251ra117-251ra117, 2014
802014
Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria
MK Muhindo, A Kakuru, P Jagannathan, A Talisuna, E Osilo, F Orukan, ...
Malaria journal 13 (1), 1-8, 2014
552014
Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children
C Maiteki-Sebuguzi, P Jagannathan, VM Yau, TD Clark, D Njama-Meya, ...
Malaria journal 7 (1), 1-11, 2008
552008
Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and …
P Jagannathan, CM Osborne, C Royce, MM Manion, JC Tilton, L Li, ...
Journal of virology 83 (6), 2728-2742, 2009
542009
Quantification of anti-parasite and anti-disease immunity to malaria as a function of age and exposure
I Rodriguez-Barraquer, E Arinaitwe, P Jagannathan, MR Kamya, ...
Elife 7, e35832, 2018
462018
Monthly sulfadoxine–pyrimethamine versus dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled …
R Kajubi, T Ochieng, A Kakuru, P Jagannathan, M Nakalembe, T Ruel, ...
The Lancet 393 (10179), 1428-1439, 2019
412019
Relationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes
J Kapisi, A Kakuru, P Jagannathan, MK Muhindo, P Natureeba, P Awori, ...
Malaria journal 16 (1), 1-11, 2017
412017
Characterizing microscopic and submicroscopic malaria parasitaemia at three sites with varied transmission intensity in Uganda
J Rek, S Katrak, H Obasi, P Nayebare, A Katureebe, E Kakande, ...
Malaria journal 15 (1), 1-8, 2016
372016
Decline of FoxP3+ regulatory CD4 T cells in peripheral blood of children heavily exposed to malaria
MJ Boyle, P Jagannathan, LA Farrington, I Eccles-James, S Wamala, ...
PLoS pathogens 11 (7), e1005041, 2015
342015
Life-threatening immune reconstitution inflammatory syndrome after Pneumocystis pneumonia: a cautionary case series
P Jagannathan, E Davis, M Jacobson, L Huang
Aids 23 (13), 1794-1796, 2009
342009
Proinflammatory IgG Fc structures in patients with severe COVID-19
S Chakraborty, J Gonzalez, K Edwards, V Mallajosyula, AS Buzzanco, ...
Nature Immunology 22 (1), 67-73, 2021
282021
Antiretroviral therapy with efavirenz accentuates pregnancy‐associated reduction of dihydroartemisinin‐piperaquine exposure during malaria chemoprevention
R Kajubi, L Huang, P Jagannathan, N Chamankhah, M Were, T Ruel, ...
Clinical Pharmacology & Therapeutics 102 (3), 520-528, 2017
272017
Pantoea agglomerans pneumonia in a heart–lung transplant recipient: case report and a review of an emerging pathogen in immunocompromised hosts
A Shubov, P Jagannathan, PV Chin‐Hong
Transplant Infectious Disease 13 (5), 536-539, 2011
272011
Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda
SG Staedke, P Jagannathan, A Yeka, H Bukirwa, K Banek, ...
Malaria journal 7 (1), 1-10, 2008
272008
Vδ2+ T cell response to malaria correlates with protection from infection but is attenuated with repeated exposure
P Jagannathan, F Lutwama, MJ Boyle, F Nankya, LA Farrington, ...
Scientific reports 7 (1), 1-12, 2017
262017
Reductions in malaria in pregnancy and adverse birth outcomes following indoor residual spraying of insecticide in Uganda
MK Muhindo, A Kakuru, P Natureeba, P Awori, P Olwoch, J Ategeka, ...
Malaria journal 15 (1), 1-9, 2016
262016
The system can't perform the operation now. Try again later.
Articles 1–20